Correlation Between Prime Medicine, and MediciNova

Can any of the company-specific risk be diversified away by investing in both Prime Medicine, and MediciNova at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prime Medicine, and MediciNova into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Prime Medicine, Common and MediciNova, you can compare the effects of market volatilities on Prime Medicine, and MediciNova and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prime Medicine, with a short position of MediciNova. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prime Medicine, and MediciNova.

Diversification Opportunities for Prime Medicine, and MediciNova

-0.7

Correlation Coefficient

Prime Medicine,  MediciNova

Excellent diversification

The 3 months correlation between Prime and MediciNova is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Prime Medicine, Common and MediciNova in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MediciNova and Prime Medicine, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prime Medicine, Common are associated (or correlated) with MediciNova. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MediciNova has no effect on the direction of Prime Medicine, i.e., Prime Medicine, and MediciNova go up and down completely randomly.

Pair Corralation between Prime Medicine, and MediciNova

Given the investment horizon of 90 days Prime Medicine, Common is expected to under-perform the MediciNova. But the etf apears to be less risky and, when comparing its historical volatility, Prime Medicine, Common is 1.47 times less risky than MediciNova. The etf trades about -0.04 of its potential returns per unit of risk. The MediciNova is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  199.00  in MediciNova on October 6, 2024 and sell it today you would earn a total of  14.00  from holding MediciNova or generate 7.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Prime Medicine, Common  vs.  MediciNova

Prime Medicine, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Prime Medicine, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Etf's primary indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the fund shareholders.

MediciNova

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in MediciNova are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, MediciNova showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Prime Medicine, and MediciNova

The main advantage of trading using opposite Prime Medicine, and MediciNova positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prime Medicine, position performs unexpectedly, MediciNova can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will offset losses from the drop in MediciNova's long position.

The idea behind Prime Medicine, Common and MediciNova pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.